Alnylam Pharmaceuticals (ALNY) Change in Inventory (2018 - 2026)
Alnylam Pharmaceuticals (ALNY) posted Change in Inventory of $3.3 million for Q1 2026, down 76.02% on a QoQ basis from $13.9 million in Q4 2025, and up 153.48% year-over-year from $1.3 million in Q1 2025.
Alnylam Pharmaceuticals (ALNY) Change in Inventory (2018 - 2026) Analysis & Trends
Alnylam Pharmaceuticals' Change in Inventory history runs 9 years deep, the most recent figure standing at $3.3 million for Q1 2026.
- Quarterly Change in Inventory rose 153.48% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 105.38% YoY) and the FY2025 annual result came in at -$8.5 million, up 37.65% from the prior year.
- Change in Inventory was $3.3 million for Q1 2026 at Alnylam Pharmaceuticals, down from $13.9 million in the prior quarter.
- Across five years, Change in Inventory topped out at $19.0 million in Q4 2022 and bottomed at -$12.0 million in Q4 2023.
- A 5-year average of -$174764.7 and a median of -$1.9 million in 2022 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 1732.63% in 2025, while the deepest fall reached 28150.0% in 2025.
- Alnylam Pharmaceuticals' Change in Inventory stood at $19.0 million in 2022, then sank by 163.18% to -$12.0 million in 2023, then jumped by 92.92% to -$849000.0 in 2024, then surged by 1732.63% to $13.9 million in 2025, then tumbled by 76.02% to $3.3 million in 2026.
- Business Quant data shows ALNY's Change in Inventory at $3.3 million in Q1 2026, $13.9 million in Q4 2025, and -$5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 3.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.32 Mn |
| Mar 31, 2026 | 3.32 Mn |
| Dec 31, 2025 | 13.86 Mn |
| Dec 31, 2025 | 13.86 Mn |
| Sep 30, 2025 | -4.98 Mn |
| Sep 30, 2025 | -4.98 Mn |
| Jun 30, 2025 | -11.14 Mn |
| Jun 30, 2025 | -11.14 Mn |
| Mar 31, 2025 | -6.22 Mn |
| Mar 31, 2025 | -6.22 Mn |
| Dec 31, 2024 | -849,000.00 |
| Dec 31, 2024 | -849,000.00 |
| Sep 30, 2024 | -5.93 Mn |
| Sep 30, 2024 | -5.93 Mn |
| Jun 30, 2024 | -6.79 Mn |
| Jun 30, 2024 | -6.79 Mn |
| Mar 31, 2024 | -22,000.00 |
| Mar 31, 2024 | -22,000.00 |
| Dec 31, 2023 | -11.99 Mn |
| Dec 31, 2023 | -11.99 Mn |